208 related articles for article (PubMed ID: 18208780)
41. [Malignant lymphoma of the thyroid].
Ohye H; Fukata S; Hirokawa M
Nihon Rinsho; 2007 Nov; 65(11):2092-8. PubMed ID: 18018576
[TBL] [Abstract][Full Text] [Related]
42. Diagnostic fine-needle aspiration cytology and immunocytochemistry analysis of a primary thyroid lymphoma presenting as an anatomic emergency.
Van den Bruel A; Drijkoningen M; Oyen R; Vanfleteren E; Bouillon R
Thyroid; 2002 Feb; 12(2):169-73. PubMed ID: 11916287
[TBL] [Abstract][Full Text] [Related]
43. Surgical intervention in chronic (Hashimoto's) thyroiditis.
Thomas CG; Rutledge RG
Ann Surg; 1981 Jun; 193(6):769-76. PubMed ID: 6894684
[TBL] [Abstract][Full Text] [Related]
44. Final Results of a Prospective Evaluation of the Predictive Value of Interim Positron Emission Tomography in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP-14 (SAKK 38/07).
Mamot C; Klingbiel D; Hitz F; Renner C; Pabst T; Driessen C; Mey U; Pless M; Bargetzi M; Krasniqi F; Gigli F; Hany T; Samarin A; Biaggi C; Rusterholz C; Dirnhofer S; Zucca E; Martinelli G
J Clin Oncol; 2015 Aug; 33(23):2523-9. PubMed ID: 26150440
[TBL] [Abstract][Full Text] [Related]
45. Burkitt-like lymphoma infiltrating a hyperfunctioning thyroid adenoma and presenting as a hot nodule.
Camera A; Magri F; Fonte R; Villani L; Della Porta MG; Fregoni V; Manna LL; Chiovato L
Thyroid; 2010 Sep; 20(9):1033-6. PubMed ID: 20825299
[TBL] [Abstract][Full Text] [Related]
46. Predictive value of (18)F-FDG hybrid PET/CT for the clinical outcome in patients with non-Hodgkin's lymphoma prior to and after autologous stem cell transplantation.
Qiao W; Zhao J; Wang C; Wang T; Xing Y
Hematology; 2010 Feb; 15(1):21-7. PubMed ID: 20132658
[TBL] [Abstract][Full Text] [Related]
47. Combined modality treatment for PET-positive non-Hodgkin lymphoma: favorable outcomes of combined modality treatment for patients with non-Hodgkin lymphoma and positive interim or postchemotherapy FDG-PET.
Halasz LM; Jacene HA; Catalano PJ; Van den Abbeele AD; Lacasce A; Mauch PM; Ng AK
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e647-54. PubMed ID: 22607911
[TBL] [Abstract][Full Text] [Related]
48. Risk-adapted dose-dense immunochemotherapy determined by interim FDG-PET in Advanced-stage diffuse large B-Cell lymphoma.
Moskowitz CH; Schöder H; Teruya-Feldstein J; Sima C; Iasonos A; Portlock CS; Straus D; Noy A; Palomba ML; O'Connor OA; Horwitz S; Weaver SA; Meikle JL; Filippa DA; Caravelli JF; Hamlin PA; Zelenetz AD
J Clin Oncol; 2010 Apr; 28(11):1896-903. PubMed ID: 20212248
[TBL] [Abstract][Full Text] [Related]
49. Thyroid hemiagenesis and Hashimoto's thyroditis-diagnostic and treatment pitfalls.
Wang M; Hou L; Chen M; Ren L; Tang P; Zhang Y; Jiang J
World J Surg Oncol; 2017 Oct; 15(1):182. PubMed ID: 28985747
[TBL] [Abstract][Full Text] [Related]
50. Development of Primary Thyroid Lymphoma during an Ultrasonographic Follow-up of Hashimoto's Thyroiditis: A Report of 9 Cases.
Mizokami T; Hamada K; Maruta T; Higashi K; Yamashita H; Noguchi Y; Noguchi H; Tajiri J
Intern Med; 2016; 55(8):943-8. PubMed ID: 27086809
[TBL] [Abstract][Full Text] [Related]
51. Problems of primary T-cell lymphoma of the thyroid gland--a case report.
Yokoyama J; Ito S; Ohba S; Fujimaki M; Sato E; Komatsu N; Ikeda K; Hanaguri M
World J Surg Oncol; 2012 Apr; 10():58. PubMed ID: 22515161
[TBL] [Abstract][Full Text] [Related]
52. Intensification treatment based on early FDG-PET in patients with high-risk diffuse large B-cell lymphoma: a phase II GELTAMO trial.
Pardal E; Coronado M; Martín A; Grande C; Marín-Niebla A; Panizo C; Bello JL; Conde E; Hernández MT; Arranz R; Bargay J; González-Barca E; Pérez-Ceballos E; Montes-Moreno S; Caballero MD
Br J Haematol; 2014 Nov; 167(3):327-36. PubMed ID: 25066542
[TBL] [Abstract][Full Text] [Related]
53. Utility of interim and end-of-treatment [(18)F]-fluorodeoxyglucose positron emission tomography-computed tomography in frontline therapy of patients with diffuse large B-cell lymphoma.
Huntington SF; Nasta SD; Schuster SJ; Doshi JA; Svoboda J
Leuk Lymphoma; 2015; 56(9):2579-84. PubMed ID: 25629993
[TBL] [Abstract][Full Text] [Related]
54. [Primary lymphoma of the thyroid: a case report].
Dem A; Traore B; Diallo BK; Mbodj M; Dieng MM; Kasse AA; Dangou JM; Diouf R; Toure P
Dakar Med; 2004; 49(1):10-2. PubMed ID: 15782469
[TBL] [Abstract][Full Text] [Related]
55. Maltoma of the thyroid and Sjögren's syndrome in a woman with Hashimoto's thyroiditis.
Androulaki A; Syriou V; Lazaris AC; Paterakis T; Pikazis D; Papathomas T; Anapliotou M
Endocr Pathol; 2006; 17(1):89-94. PubMed ID: 16760585
[TBL] [Abstract][Full Text] [Related]
56. B cell lymphoma of the thyroid in Hashimoto's thyroiditis monitored by fine-needle aspiration cytology.
Jayaram G; Rani S; Raina V; Singh CH; Chandra M; Marwaha RK
Diagn Cytopathol; 1990; 6(2):130-3. PubMed ID: 2338037
[TBL] [Abstract][Full Text] [Related]
57. Surgical treatment of primitive thyroid lymphoma.
Avenia N; Ragusa M; Cirocchi R; Puxeddu E; Cavaliere A; De Feo P; Sidoni A; Roila F; Sanguinetti A; Puma F
Tumori; 2009; 95(6):712-9. PubMed ID: 20210235
[TBL] [Abstract][Full Text] [Related]
58. Bilateral primary renal lymphoma in a pediatric patient: staging and response evaluation with ¹⁸F-FDG PET/CT.
Dhull VS; Mukherjee A; Karunanithi S; Durgapal P; Bal C; Kumar R
Rev Esp Med Nucl Imagen Mol; 2015; 34(1):49-52. PubMed ID: 25065972
[TBL] [Abstract][Full Text] [Related]
59. Primary hepatic (extranodal) lymphoma: utility of [(18)F]fluorodeoxyglucose-PET/CT.
Seshadri N; Ananthasivan R; Kavindran R; Srikanth G; Chandra S
Cancer Imaging; 2010 Oct; 10(1):194-7. PubMed ID: 20926362
[TBL] [Abstract][Full Text] [Related]
60. Hodgkin's lymphoma of the thyroid: a clinicopathologic study of five cases and review of the literature.
Wang SA; Rahemtullah A; Faquin WC; Roepke J; Harris NL; Hasserjian RP
Mod Pathol; 2005 Dec; 18(12):1577-84. PubMed ID: 16258502
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
